Stay updated on Fruquintinib in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib in Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:44:47.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the clinical trial study details related to the evaluation of the safety, tolerability, and pharmacokinetics of fruquintinib in patients with advanced solid tumors, metastatic colorectal cancer, and metastatic breast cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:35:46.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying requirements such as age, health status, and prior treatments. Previously, this section only indicated that no information was provided.
    Difference
    43%
    Check dated 2024-05-22T21:35:31.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:54:31.000Z thumbnail image

Stay in the know with updates to Fruquintinib in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.